Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Biodesix Community
NasdaqGM:BDSX Community
2
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Biodesix
Popular
Undervalued
Overvalued
Community Investing Ideas
Biodesix
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Sales Force Expansion And CLARIFY Study Will Boost Test Adoption
Key Takeaways Expansion of sales force and test adoption, along with CLARIFY study results, are expected to drive revenue growth and improve margins. Diagnostic services growth and potential profitability could enhance investor confidence and diversify revenues through new partnerships and innovative test developments.
View narrative
US$2.90
FV
83.6% undervalued
intrinsic discount
24.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
BDSX
BDSX
Biodesix
Your Fair Value
US$
Current Price
US$0.47
35.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-65m
163m
2015
2018
2021
2024
2025
2027
2030
Revenue US$162.7m
Earnings US$12.0m
Advanced
Set Fair Value